METAHEPS
Desconocido
TransBioLine: Translational Safety Biomarker Pipeline TransBioLine Enabling development and implementation of n...
METAHEPS GMBH
participó en un
H2020:
H2020-JTI-IMI2-2017-13-two-stage
Qualified biomarkers help to optimize drug development and patient safety, yet for the regulatory acceptance of safety biomarkers substantia...
2019-04-08 - 2025-01-31 | Financiado
2019-04-08 - 2025-01-31 | Financiado
DILITEST: Diagnosis and Exclusion of Drug Induced Liver Injury by using Patient Blood Samples DILITEST
METAHEPS GMBH
tramitó un
H2020:
H2020-SMEInst-2014-2015
Ca. 1 billion USD are lost by late stage failures per one successfully marketed drug. Idiosyncratic Drug induced Liver injury (iDILI) is one...
2015-12-09 - 2016-04-30 | Financiado
2015-12-09 - 2016-04-30 | Financiado
* No se disponen de datos de la empresa actual.